Sun Pharma

News

Sun Pharma says talk of $10bn Organon bid is 'speculative'

India's Sun Pharma has downplayed a rumour that it is in talks to acquire women's health specialist and MSD spinout Organon for $10bn.

News

Sun Pharma overturns block on alopecia drug launch in US

Sun Pharma successfully removed an injunction on the launch of its Leqselvi for alopecia areata, a common form of hair loss, in the US.

News

Sun Pharma buys Checkpoint and its new cancer drug

Sun Pharma has agreed to acquire Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running short on cash.

News

Sun Pharma, Taro Pharma, and Antibe Therapeutics logos

Sun Pharma unit poised to buy Canadian biotech Antibe

Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain and inflammation.

News

Incyte blocks US launch of Sun Pharma's alopecia drug

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata.

News

Sun Pharma reaches deal to buy out Taro in $347m deal

India’s Sun Pharma has signed an agreement to take full control of Israeli generic drugmaker Taro Pharmaceutical Industries, taking it into private hands.

Sun Pharma says talk of $10bn Organon bid is 'speculative'

Sun Pharma overturns block on alopecia drug launch in US

Sun Pharma buys Checkpoint and its new cancer drug

Sun Pharma unit poised to buy Canadian biotech Antibe

Incyte blocks US launch of Sun Pharma's alopecia drug

Sun Pharma reaches deal to buy out Taro in $347m deal

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

Sun Pharma

Editor's Picks